Tetrous Announces Additional U.S. Patent for EnFix in Sports Medicine

Tetrous, Inc., a regenerative medicine company, announced it was issued a patent (U.S. Patent Number 11,759,548) specifically related to the EnFix family of demineralized cortical bone fiber implants and their method of manufacture.

EnFix RC™, the first product in the EnFix family, is a procedure-specific implant for rotator cuff repair. It is...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us